Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Scientists discover link between common medications and serious falls in older men

  • Sleepy fruitflies get mellow

  • Research grasps how brain plans gripping motion

  • How to digitally stoke that old-time auction fever

  • Autism costs estimated to reach nearly 0 billion, potentially trillion, by 2025

  • Coffee consumption habits impact the risk of mild cognitive impairment

  • Very early birth linked to introversion, neuroticism, risk aversion in adulthood

  • Where memory is encoded and retrieved: New findings in a long-standing debate

  • Neurology researchers evaluate evidence base for tests for clinical cognitive assessment

  • Majority rule: Why conformity can actually be a good thing

  •